Related Experiment Video
Updated: Apr 29, 2026
Fetal Echocardiography and Pulsed-wave Doppler Ultrasound in a Rabbit Model of Intrauterine Growth Restriction
Published on: June 29, 2013
Customised versus population-based growth charts as a screening tool for detecting small for gestational age infants
Angela E Carberry1, Adrienne Gordon, Diana M Bond
1Sydney School of Public Health, University of Sydney, Camperdown, Sydney, NSW, Australia, 2050.
Insights
No randomized trials were found comparing customized versus population-based growth charts for screening fetal growth. Further research is needed to determine the benefits and harms of customized charts for detecting small for gestational age infants.
Area of Science:
- Obstetrics and Gynecology
- Perinatal Medicine
- Evidence-Based Medicine
Background:
- Fetal growth restriction is a major pregnancy complication, often resulting in infants who are small for gestational age (SGA).
- Identifying SGA infants is crucial due to their increased risk of perinatal morbidity and mortality.
- Current clinical assessments for SGA are often insufficient, highlighting the need for improved screening tools.
Purpose of the Study:
- To evaluate the benefits and harms of using customized growth charts versus population-based growth charts for screening fetal growth in pregnant women.
Main Methods:
- A systematic search of the Cochrane Pregnancy and Childbirth Group's Trials Register was conducted.
- Published guidelines and reference lists of review articles were also reviewed.
- Inclusion criteria focused on randomized, quasi-randomized, or cluster-randomized trials comparing customized and population-based growth charts for fetal growth screening.
Main Results:
- No randomized clinical trials met the inclusion criteria for this review.
- Therefore, no direct comparative evidence exists from randomized trials regarding the effectiveness of customized versus population-based growth charts.
Conclusions:
- There is a lack of high-quality randomized trial evidence to support the use of customized growth charts over population-based charts.
- Further large-scale randomized trials are necessary to assess the benefits and harms, including perinatal mortality, associated with customized growth charts in various settings and measurement methods.
Background:
Fetal growth restriction is defined as failure to reach growth potential and considered one of the major complications of pregnancy. These infants are often, although not universally, small for gestational age (SGA). SGA is defined as a weight less than a specified percentile (usually the 10th percentile). Identification of SGA infants is important because these infants are at increased risk of perinatal morbidity and mortality. Screening for SGA is a challenge for all maternity care providers and current methods of clinical assessment fail to detect many infants who are SGA. Large observational studies suggest that customised growth charts may be better able to differentiate between constitutional and pathologic smallness. Customised charts adjust for physiological variables such as maternal weight and height, ethnicity and parity.
Objectives:
To assess the benefits and harms of using population-based growth charts compared with customised growth charts as a screening tool for detection of fetal growth in pregnant women.
Search Methods:
We searched the Cochrane Pregnancy and Childbirth Group's Trials Register (12 March 2014), reviewed published guidelines and searched the reference lists of review articles.
Selection Criteria:
Randomised, quasi-randomised or cluster-randomised clinical trials comparing customised versus population-based growth charts used as a screening tool for detection of fetal growth in pregnant women.
Data Collection And Analysis:
Two review authors independently assessed trials for inclusion.
Main Results:
No randomised trials met the inclusion criteria.
Authors' Conclusions:
There is no randomised trial evidence currently available. Further randomised trials are required to accurately assess whether the improvement in detection shown is secondary to customised charts alone or an effect of the policy change. Future research in large trials is needed to investigate the benefits and harms (including perinatal mortality) of using customised growth charts in different settings and for both fundal height and ultrasound measurements.
Related Concept Videos
00:57Population Growth
01:52Regression Toward the Mean
01:12Analysis of Population Pharmacokinetic Data